Havas Revenue Up 3.5% Year-On-Year With Small APAC Growth
Havas Group has reported that its revenue climbed 3.5 per cent to €611 million (just over AU$1 billion) in the first quarter of this year, compared to Q1 2022
Stay updated with breaking news from Trinity Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Havas Group has reported that its revenue climbed 3.5 per cent to €611 million (just over AU$1 billion) in the first quarter of this year, compared to Q1 2022
Organic growth of 1.1%.
Revenues1 up 3.3% (+2.0% at constant currency and perimeter) compared to the first quarter of 2022, in line with expectations Growth across all Canal+ Group businesses, particularly Studiocanal
In 2021, Bayer took its media planning and buying in-house. Two years later, why haven’t any other pharma giants followed its lead?
Havas Health & You debuts Archipelago, a value and access consultancy. From PR Week